Publication | Closed Access

Practical synthesis of (R)-(+)-6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-hydroxyphenyl)hexanoic acid: a key intermediate for a therapeutic drug for neurodegenerative diseases

Medicinal ChemistryNeurodegenerative DiseasesHexanoic AcidEngineeringNatural SciencesDiversity-oriented SynthesisOrganic ChemistryPharmacologyPharmaceutical ChemistrySynthetic ChemistryTherapeutic DrugBiomolecular EngineeringNatural Product Synthesis